Skip to main content

Clinical Trials › NCT06133049

Active, Not Recruiting

A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Multiple Sclerosis and Their Infants

Sponsored by Bristol-Myers Squibb

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
2961
Target enrollment
1
U.S. states
Mar 2021
Start date
Aug 2031
Expected completion

Interventions / Treatments

OzanimodSelect DMTs other than ozanimodNo DMTs

Conditions studied

Multiple Sclerosis

Where this trial is running (1 site)

Minnesota1 site
Eden Prairie

MS centers in Minnesota

Compare treatment centers near a trial site by center type, providers and trials.

View Minnesota centers
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play